Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer
Colorectal cancer is a major health burden, and a leading cause of cancer-related deaths in industrialized countries. The steady improvements in surgery and chemotherapy have improved survival, but the ability to identify high- and low-risk patients is still somewhat poor. Molecular biology has, ove...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/12/12/9426/ |
id |
doaj-dd5269a398c749768b0586db6aa824f7 |
---|---|
record_format |
Article |
spelling |
doaj-dd5269a398c749768b0586db6aa824f72020-11-25T00:55:03ZengMDPI AGInternational Journal of Molecular Sciences1422-00672011-12-0112129426943910.3390/ijms12129426Genetic and Epigenetic Traits as Biomarkers in Colorectal CancerMarianne BergKjetil SøreideColorectal cancer is a major health burden, and a leading cause of cancer-related deaths in industrialized countries. The steady improvements in surgery and chemotherapy have improved survival, but the ability to identify high- and low-risk patients is still somewhat poor. Molecular biology has, over the years, given insight into basic principles of colorectal cancer initiation and development. These findings include aberrations increasing risk of tumor development, genetic changes associated with the stepwise progression of the disease, and errors predicting response to a specific treatment. Potential biomarkers in colorectal cancer are extensively studied, and how the molecular aberrations relate to clinical features. Yet, little of this knowledge has been possible to transfer into clinical practice. In this review, an overview of colorectal cancer genetics will be given, as well as how aberrations found in this tumor type are proposed as biomarkers for risk prediction, as diagnostic tools, for prognosis or prediction of treatment outcome.http://www.mdpi.com/1422-0067/12/12/9426/biomarkercolorectal cancermutationsepigeneticsmicrosatellite instabilitychromosomal instabilityrisk markerdiagnostic markerprognostic markerpredictive marker |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marianne Berg Kjetil Søreide |
spellingShingle |
Marianne Berg Kjetil Søreide Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer International Journal of Molecular Sciences biomarker colorectal cancer mutations epigenetics microsatellite instability chromosomal instability risk marker diagnostic marker prognostic marker predictive marker |
author_facet |
Marianne Berg Kjetil Søreide |
author_sort |
Marianne Berg |
title |
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer |
title_short |
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer |
title_full |
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer |
title_fullStr |
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer |
title_full_unstemmed |
Genetic and Epigenetic Traits as Biomarkers in Colorectal Cancer |
title_sort |
genetic and epigenetic traits as biomarkers in colorectal cancer |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2011-12-01 |
description |
Colorectal cancer is a major health burden, and a leading cause of cancer-related deaths in industrialized countries. The steady improvements in surgery and chemotherapy have improved survival, but the ability to identify high- and low-risk patients is still somewhat poor. Molecular biology has, over the years, given insight into basic principles of colorectal cancer initiation and development. These findings include aberrations increasing risk of tumor development, genetic changes associated with the stepwise progression of the disease, and errors predicting response to a specific treatment. Potential biomarkers in colorectal cancer are extensively studied, and how the molecular aberrations relate to clinical features. Yet, little of this knowledge has been possible to transfer into clinical practice. In this review, an overview of colorectal cancer genetics will be given, as well as how aberrations found in this tumor type are proposed as biomarkers for risk prediction, as diagnostic tools, for prognosis or prediction of treatment outcome. |
topic |
biomarker colorectal cancer mutations epigenetics microsatellite instability chromosomal instability risk marker diagnostic marker prognostic marker predictive marker |
url |
http://www.mdpi.com/1422-0067/12/12/9426/ |
work_keys_str_mv |
AT marianneberg geneticandepigenetictraitsasbiomarkersincolorectalcancer AT kjetilsøreide geneticandepigenetictraitsasbiomarkersincolorectalcancer |
_version_ |
1725232325889884160 |